ELOX

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)

About ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.75
52 Week Low
$0.00
Market cap
465,400
Dividend yield
0.00%
Volume
--
Avg. volume
9,355
P/E ratio
--

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.75
52 Week Low
$0.00
Market cap
465,400
Dividend yield
0.00%
Volume
--
Avg. volume
9,355
P/E ratio
--